{
    "paper_id": "bfbbf04feedacf1117e45338a1f2cde879f17275",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "Lina",
                "middle": [],
                "last": "Zabuliene",
                "suffix": "",
                "affiliation": {
                    "laboratory": "Ioannis Ilias Endocrine Unit",
                    "institution": "Elena Venizelou Hospital",
                    "location": {
                        "postCode": "GR-11521",
                        "region": "Athens",
                        "country": "Greece"
                    }
                },
                "email": "lina.zabuliene@mf.vu.lt."
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Acutely ill patients present often with hyperglycemia (caused among other factors by endogenous stress-induced glucocorticoid hypersecretion) [1] . In preliminary reports, presenting clinical characteristics of patients with the novel Covid-19 infection, hyperglycemia was noted in 51% of cases [2] . Interestingly, transient hyperglycemia was also noted in patients with SARS (Severe Acute Respiratory Syndrome in 2003, caused by another coronavirus, closely related to Covid-19, SARS-CoV) [3] ; the virus leads to transient impairment of pancreatic islet cell function [3] . Additionally, the also closely related, Middle Eastern Respiratory Syndrome (MERS in 2013) coronavirus (MERS-CoV) as well as human coronavirus-EMC are anchored to host cells via dipeptidyl peptidase 4 (DPP-4, which physiologically is implicated in the modulation of insulin action and as an enzyme plays a major role in glucose metabolism and is responsible for the degradation of incretins such as glucagon like peptide \u22121, GLP-1) [4, 5] . Thus, we believe that the hyperglycemia noted in patients with Covid-19 may be caused via such (or analogous) mechanisms; this remains to be assessed by ulterior studies. Nevertheless, the issue of hyperglycemia should not be overlooked, since it may lead to additional immune suppression and further complications [6] .",
            "cite_spans": [
                {
                    "start": 142,
                    "end": 145,
                    "text": "[1]",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 295,
                    "end": 298,
                    "text": "[2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 491,
                    "end": 494,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 571,
                    "end": 574,
                    "text": "[3]",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 1009,
                    "end": 1012,
                    "text": "[4,",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1013,
                    "end": 1015,
                    "text": "5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1333,
                    "end": 1336,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                }
            ],
            "ref_spans": [],
            "section": ""
        },
        {
            "text": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Declaration of Competing Interest"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Stress hyperglycemia: an essential survival response!",
            "authors": [
                {
                    "first": "P",
                    "middle": [
                        "E"
                    ],
                    "last": "Marik",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bellomo",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Crit Care",
            "volume": "17",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507--520",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "K"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "J"
                    ],
                    "last": "Ji",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Acta Diabetol",
            "volume": "47",
            "issn": "",
            "pages": "193--202",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "Polymorphisms in dipeptidyl peptidase 4 reduce host cell entry of Middle East respiratory syndrome coronavirus",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Kleine-Weber",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Schroeder",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Kruger",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "",
            "pages": "155--68",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Raj",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Smits",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nature",
            "volume": "495",
            "issn": "",
            "pages": "251--255",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Relationship between hyperglycemia and infection in critically ill patients",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "O"
                    ],
                    "last": "Butler",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "F"
                    ],
                    "last": "Btaiche",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Alaniz",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Pharmacotherapy",
            "volume": "25",
            "issn": "",
            "pages": "963--76",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "TABREF0": {
            "text": "Contents lists available at ScienceDirect Medical Hypotheses journal homepage: www.elsevier.com/locate/mehy Letter to Editors Hyperglycemia and the novel Covid-19 infection: Possible pathophysiologic mechanisms A R T I C L E I N F O",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": []
}